Our results also indicated that the multilevel microfluidic device offers reliable quantitative data collection, and thus is applicable for the study of the effect of breast cancer-derived soluble factors on CCL19-induced DC chemotaxis. This evidence concerns the gene CCL19 and breast cancer.